Mankind Pharma lists with 20.37% premium on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Mankind Pharma has debuted at Rs 1300.00 on the BSE, up by 220 points or 20.37% from its issue price of Rs 1080.
The scrip is currently trading at Rs 1388.30, up by 308.30 points or 28.55% from its issue price. It has touched a high and low of Rs 1395.00 and Rs 1300.00 respectively. So far 7.19 lakh shares were traded on the counter.
The offering, which was open for subscription between April 25, 2023 and April 27, 2023 was subscribed over 15 times. The issue price was fixed at Rs 1080 per share i.e. at upper end of price band of Rs 1026-1080 apiece.
Mankind Pharma develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.
